EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Early CMV-specific T cell immune reconstitution after kidney transplantation: A prospective AIM-based cohort study

Sara Belga, Chad Poloni, Robert C Wright, Gale Ladua, Andrew Sze, Dilpreet Bharaj, Cindy Luo, Xiaojiao Wang, James Lan, John Gill, Laura Cook, Theodore S Steiner

Transplant Immunology · 2026

DOI: 10.1016/j.trim.2026.102441 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Transplant Immunology, 2026. Verfasst von Sara Belga und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, BC, Canada; Immunity and Infection Research Centr…. Hauptthemen laut MEDLINE: Kidney Transplantation, Cytomegalovirus Infections, Cytomegalovirus, Immune Reconstitution. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Vancouver Coastal Health Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Cytomegalovirus (CMV) remains a major cause of morbidity following kidney transplantation (KT). We applied flow cytometry-based phenotyping and activation-induced marker (AIM) assays to characterize early immune reconstitution and CMV-specific T-cell dynamics after KT and to determine whether early AIM responses are associated with clinically significant CMV infection (CS-CMVi). METHODS: Twenty-nine adult KT recipients were followed prospectively for 12 months: 13 donor CMV-positive/recipient CMV-negative (D+/R-) and 16 CMV-seropositive recipients (R+). CMV-specific CD4+ and CD8+ T cells were quantified by AIM assay at 2 weeks and at 3, 6, 9, and 12 months. CS-CMVi was defined as CMV infection requiring antiviral therapy. RESULTS: Immune reconstitution featured expansion of CD4+ TEMRA and Th1-like cells with contraction of Th2/Th17 subsets. Seven recipients (24%) developed CS-CMVi, including five D+/R-. Early CD4+-predominant CMV-specific responses shifted toward CD8+ expansion with viral replication. At 2 weeks, the CMV-specific CD4+: CD8+ ratio was associated with CS-CMVi (AUC 0.83, p = 0.012); a cut-off ≥1.37 yielded 86% sensitivity and 71% specificity. After 6 months, CMV serostatus shaped Th-cell activation, with R+ recipients showing greater Th1/Treg and reduced Th2/Th17 responsiveness. CONCLUSION: Early CMV-specific CD4+/CD8+ imbalances measured by AIM are associated with CS-CMVi and reflect distinct trajectories of immune reconstitution after KT. These findings support prospective evaluation of CMV-AIM assays as precision immune-monitoring tools in larger studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationCytomegalovirus InfectionsCytomegalovirusImmune ReconstitutionCD8-Positive T-LymphocytesCD4-Positive T-LymphocytesHumansProspective StudiesFemaleMaleMiddle AgedAdultLymphocyte ActivationFollow-Up Studies

Stichwörter der Autor:innen

Activation-induced marker (AIM) assayCell-mediated immunityCytomegalovirus (CMV)Immune reconstitutionKidney transplantation

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, BC, Canada; Immunity and Infection Research Centre, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada;…
  • British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada.
  • British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, BC, Canada.
  • Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, BC, Canada; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

Förderung

  • Vancouver Coastal Health Research Institute

Zitieren

APA

Belga, S., Poloni, C., Wright, R. C., Ladua, G., Sze, A., Bharaj, D., Luo, C., Wang, X., Lan, J., Gill, J., Cook, L., & Steiner, T. S. (2026). Early CMV-specific T cell immune reconstitution after kidney transplantation: A prospective AIM-based cohort study. Transplant Immunology. https://doi.org/10.1016/j.trim.2026.102441

Vancouver

Belga S, Poloni C, Wright RC, Ladua G, Sze A, Bharaj D, et al. Early CMV-specific T cell immune reconstitution after kidney transplantation: A prospective AIM-based cohort study. Transplant Immunology. 2026. doi:10.1016/j.trim.2026.102441

BibTeX
@article{Belga2026,
  author = {Belga, Sara and Poloni, Chad and Wright, Robert C and Ladua, Gale and Sze, Andrew and Bharaj, Dilpreet and Luo, Cindy and Wang, Xiaojiao and Lan, James and Gill, John and Cook, Laura and Steiner, Theodore S},
  title = {Early CMV-specific T cell immune reconstitution after kidney transplantation: A prospective AIM-based cohort study},
  journal = {Transplant Immunology},
  year = {2026},
  doi = {10.1016/j.trim.2026.102441}
}
Kostenlos starten →